CLOV vs RCUS
Clover Health Investments Corp (CLOV) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
CLOV currently screens at market cap $1.55B. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the CLOV and RCUS stock pages for the full models.
Not investment advice.